Sentry Investments’s Amgen AMGN Stock Holding History

Sentry Investments’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-29,002	Closed	-$5.04M	–	198
2017 Q4	$5.04M	Buy	+29,002	New	+$5.13M	0.06%	135

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Sentry Investments's AMGN Position: Q1 2018 in Review

Sentry Investments sold out of Amgen (AMGN) in Q1 2018, closing a stake of 29,002 shares — an estimated $5.04M sold.

Sentry Investments first reported a position in AMGN in Q4 2017 and held it in 1 quarter. The position peaked at $5.04M in Q4 2017. 1,749 funds tracked by Wall St. Rank hold AMGN as of Q1 2018.

Sentry Investments reported no remaining Amgen position as of Q1 2018 after selling out during the quarter.
Sentry Investments sold 29,002 Amgen shares in Q1 2018, an estimated $5.04M.
Sentry Investments first reported a position in Amgen in Q4 2017 and held it in 1 quarter.
Sentry Investments's Amgen position peaked at $5.04M in Q4 2017.
1,749 funds tracked by Wall St. Rank held Amgen as of Q1 2018.

Based on Sentry Investments's 13F filing for Q1 2018, filed 11 May 2018.